Supplier
Deliver My Meds Corp
Deliver My Meds Corp was paid $25K by Medicaid between Mar 2021 and Aug 2024, across 8 billing codes. Its largest line is A4239, Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service — 33% of everything it billed.
33Billing provider infoDELIVER MY MEDS CORP
RICHARDSON, TX 75081
RICHARDSON, TX 75081
33aNPI1265990113assigned 03/11/2019
33bProvider typePharmacy
28Total paid$25K
24GClaims1,032
24DCodes billed8
24AFirst – last monthMar 2021 – Aug 2024
Compared with peers
Next to other Pharmacy providers in Texas
Rank by total paid#9 of 26
Median peer was paid$2K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 364 | $13K | |
| 2022 | 90 | $3K | |
| 2023 | 449 | $7K | |
| 2024incomplete | 129 | $2K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| A4239 | Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | 33% | 526 | 470 | $8K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 16% | 106 | 97 | $4K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 14% | 89 | 85 | $4K |
| 0012A | 12% | 93 | 92 | $3K | |
| 0011A | 10.0% | 76 | 75 | $3K | |
| K0553 | Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | 9.2% | 70 | 66 | $2K |
| K0554 | Receiver (monitor), dedicated, for use with therapeutic glucose continuous monitor system | 3.1% | 20 | 20 | $790.40 |
| E2103 | Non-adjunctive, non-implanted continuous glucose monitor or receiver | 3.0% | 52 | 48 | $750.25 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHAUDHARY, SHAHBAZ (PRESIDENT)